MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sumitomo Pharma America, Inc. (SMPA) today announced that the first patient in its study evaluating DSP-3077 in the treatment of non-syndromic retinitis pigmentosa (RP) has undergone subretinal implantation. DSP-307…
Author: Business Wire
National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results
ALPHARETTA, Ga.–(BUSINESS WIRE)– #nationalvision–National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its second quarter 2026 results.
National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results
ALPHARETTA, Ga.–(BUSINESS WIRE)– #nationalvision–National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its second quarter 2026 results.
Omega Ophthalmics LLC Raises $7 Million in a Series A Financing and Schedules FDA Pre-Submission Meeting to Advance Gemini Refractive Capsule Toward U.S. Approval
LEXINGTON, Ky.–(BUSINESS WIRE)–Omega Ophthalmics Raises $7 Million in a Series A Financing and Schedules FDA Pre-Submission Meeting to Advance Gemini Refractive Capsule
Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe
BOLOGNA, Italy & MILAN, Italy–(BUSINESS WIRE)–Alfasigma S.p.A. (“Alfasigma”), a global pharmaceutical company, today announced that it has entered into a share purchase agreement with SEVER Life Sciences B.V. (“SEVER”) for the sale of 100% of the sha…
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
GENEVA–(BUSINESS WIRE)–New Product Launches and Strong Commercial Execution Drive Alcon’s Second-Quarter 2026 Growth
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
GENEVA–(BUSINESS WIRE)–New Product Launches and Strong Commercial Execution Drive Alcon’s Second-Quarter 2026 Growth
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Q2 2026 Earnings Release
ForSight Robotics Demonstrates Fully Robotic-Assisted Cataract Surgery Within the Standard Clinical Workflow of the World's Most Commonly Performed Surgical Procedure
CAESAREA, Israel–(BUSINESS WIRE)–ForSight Robotics, a global pioneer in robotic eye surgery, today announced a significant milestone in the clinical evolution of ophthalmic robotics, demonstrating that fully robotic-assisted cataract surgery can be s…
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today reported recent bus…
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its Board of Directors. At the request of Bausch Health…
Warby Parker Announces Second Quarter 2026 Results
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the second quarter ended June 30, 2026. Highlights Delive…
STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that followin…
STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results i…
Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg
BENGALURU, India & BRIDGEWATER, N.J.–(BUSINESS WIRE)– #biosimilar–Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg, Used to Treat Various Types of Ophthalmology Conditions
Ne laissez pas « le Grand Flou » nuire à l’apprentissage des enfants
OTTAWA, Ontario–(BUSINESS WIRE)–Les examens de la vue jouent un rôle essentiel pour donner à chaque enfant toutes les chances de réussir en classe. C’est pourquoi l’ACO lance une nouvelle campagne de sensibilisation numérique sur les soins oculaires …
Don't Let "The Blur" Stand in the Way of Children's Learning
OTTAWA, Ontario–(BUSINESS WIRE)–Ensuring every child is set up for success in the classroom, eye exams play a critical role in this success. This is why CAO is launching its digital awareness campaign to address children’s vision care and the rising …
Glaukos Announces Second Quarter 2026 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced finan…
Science Corp. Names Nevada Sanchez as Executive Vice President of Engineering
ALAMEDA, Calif.–(BUSINESS WIRE)–Science Corporation, the full-stack neural engineering and brain-computer interface (BCI) company focused on restoring and extending life, today announced the appointment of Nevada Sanchez as Executive Vice President o…
Qlaris Bio Appoints Parisa Zamiri, M.D., Ph.D., to Board of Directors
DEDHAM, Mass.–(BUSINESS WIRE)–Qlaris Bio, Inc., a clinical-stage biotechnology company focused on developing first-in-class therapies for glaucoma, today announced the appointment of Parisa Zamiri, M.D., Ph.D., to its board of directors. Dr. Zamiri’s…